Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in MET-Addicted Cancer

por Kim, Jooseok, Park, Kyung Eui, Jeong, Yoo-Seong, Kim, YeongMun, Park, Hayeon, Nam, Ji-Hye, Jung, Kyungsoo, Son, Woo Sung, Jung, Hun Soon, Lee, Jong-Hwa, Jeong, Seong Hoon, Kim, Nam Ah, Ha, Jae Du, Cho, Sung Yun, Choi, Yoon-La, Chung, Suk-Jae, Choi, Jun Young, Hong, Sungyoul, Shin, Young Kee
Publicado 2020